Simeticone: Difference between revisions
imported>Muhammad Anas Sidik No edit summary |
imported>Boghog consistent citation formatting |
||
| Line 1: | Line 1: | ||
{{ | {{Short description|Anti-foaming agent used to reduce bloating, discomfort or pain caused by excessive gas}} | ||
{{Missing information|the history of simeticone|date=September 2021}} | {{Missing information|the history of simeticone|date=September 2021}} | ||
{{ | {{Infobox drug | ||
| Verifiedfields = changed | | Verifiedfields = changed | ||
| verifiedrevid = 417768970 | | verifiedrevid = 417768970 | ||
| IUPAC_name = Poly(dimethylsiloxane), silicon dioxide | | IUPAC_name = Poly(dimethylsiloxane), silicon dioxide | ||
| image = Simethicone structure.svg | | image = Simethicone structure.svg | ||
<!--Clinical data --> | <!--Clinical data -->| image_class = skin-invert-image | ||
| tradename = Infacol, Wind-eze, WindSetlers, | | tradename = Infacol, Wind-eze, WindSetlers, others | ||
|USAN = | | USAN = Simethicone<ref>{{cite web|title=Simethicone names|url=https://www.drugs.com/international/simethicone.html|publisher=Drugs.com|access-date=27 August 2017}}</ref> | ||
| Drugs.com = {{drugs.com|monograph|simethicone}} | | Drugs.com = {{drugs.com|monograph|simethicone}} | ||
| pregnancy_category = C | | pregnancy_category = C | ||
| legal_US = OTC | | legal_US = OTC | ||
| routes_of_administration = Oral | | routes_of_administration = [[Oral administration|Oral]] | ||
<!--Pharmacokinetic data --> | <!--Pharmacokinetic data -->| bioavailability = None | ||
| bioavailability = None | |||
| protein_bound = 0% | | protein_bound = 0% | ||
| metabolism = Not metabolized | | metabolism = Not metabolized | ||
| elimination_half-life = N/A | | elimination_half-life = N/A | ||
| excretion = Feces | | excretion = Feces | ||
<!--Identifiers --> | <!--Identifiers -->| CAS_number_Ref = {{cascite|correct|??}} | ||
| CAS_number_Ref = {{cascite|correct|??}} | |||
| CAS_number = 8050-81-5 | | CAS_number = 8050-81-5 | ||
| ATC_prefix = A03 | | ATC_prefix = A03 | ||
| Line 31: | Line 29: | ||
| ChEMBL_Ref = {{ebicite|changed|EBI}} | | ChEMBL_Ref = {{ebicite|changed|EBI}} | ||
| ChEMBL = 1200838 | | ChEMBL = 1200838 | ||
<!--Chemical data --> | <!--Chemical data -->| chemical_formula = (C<sub>2</sub>H<sub>6</sub>OSi)<sub>n</sub> · (SiO<sub>2</sub>)<sub>m</sub> | ||
| chemical_formula = (C<sub>2</sub>H<sub>6</sub>OSi)<sub>n</sub> · (SiO<sub>2</sub>)<sub>m</sub> | |||
| molecular_weight = Variable | | molecular_weight = Variable | ||
}} | }} | ||
| Line 39: | Line 36: | ||
==Medical uses== | ==Medical uses== | ||
[[File:Simethiconetablets.jpg|thumb|Simethicone tablets]] | [[File:Simethiconetablets.jpg|thumb|Simethicone tablets]] | ||
Simethicone is used to relieve the symptoms of excessive gas in the [[gastrointestinal tract]], namely bloating, burping, and flatulence.<ref name=USOTClabel>{{cite web|title=Simethicone tablet|url=https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d93ff75d-9cdb-476c-bb65-eabeefb91a34|publisher=NIH DailyMed|access-date=27 August 2017|date=April 2016}}</ref><ref>{{cite web|title=Simeticone|url=https://www.nhs.uk/medicines/simeticone/|publisher=[[NHS]]|language=en|date=10 October 2019|access-date=30 January 2020}}</ref> While there is a lack of conclusive evidence that simethicone is effective for this use,<ref>{{cite web| vauthors = Modi R, Clearfield HR, Levitt M | title=Belching, Bloating and Flatulence|url=http://patients.gi.org/topics/belching-bloating-and-flatulence/|publisher=American College of Gastroenterology|language=en|date=July 2013}}</ref><ref name="drugs.com">{{Cite web | url = https://www.drugs.com/monograph/simethicone.html | title = Simethicone | publisher = [[drugs.com]] | quote = Efficacy not established for the symptomatic relief of immediate postprandial upper abdominal distress}}</ref>{{Failed verification|date=January 2020|reason=Flatulence/bloating and IPPUAD are separate sections in source}} studies have shown that it can relieve symptoms of [[functional dyspepsia]]<ref>{{cite journal | vauthors = Holtmann G, Gschossmann J, Mayr P, Talley NJ | title = A randomized placebo-controlled trial of simethicone and cisapride for the treatment of patients with functional dyspepsia | journal = Alimentary Pharmacology & Therapeutics | volume = 16 | issue = 9 | pages = 1641–1648 | date = September 2002 | pmid = 12197843 | doi = 10.1046/j.1365-2036.2002.01322.x | publisher = Wiley | s2cid = 23286985 | doi-access = }}</ref> and [[bloating|functional bloating]].<ref>{{cite journal | vauthors = Burta O, Iacobescu C, Mateescu RB, Nicolaie T, Tiuca N, Pop CS | title = Efficacy and safety of APT036 versus simethicone in the treatment of functional bloating: a multicentre, randomised, double-blind, parallel group, clinical study | journal = Translational Gastroenterology and Hepatology | volume = 3 | issue = 72 | pages = 72 | date = 25 September 2018 | pmid = 30511026 | pmc = 6256934 | doi = 10.21037/tgh.2018.09.11 | publisher = AME Publications | doi-access = free }}</ref> | |||
It has not been fully established that | It has not been fully established that simethicone is useful to treat [[Baby colic|colic]] in babies,<ref>{{cite journal | vauthors = Biagioli E, Tarasco V, Lingua C, Moja L, Savino F | title = Pain-relieving agents for infantile colic | journal = The Cochrane Database of Systematic Reviews | volume = 2016 | issue = 9 | date = September 2016 | pmid = 27631535 | pmc = 6457752 | doi = 10.1002/14651858.CD009999.pub2 | article-number = CD009999 }}</ref> and it is not recommended for this purpose.<ref name="drugs.com"/> A study in the United Kingdom reported that according to parental perception simethicone helped infant colic in some cases.<ref>{{cite journal | vauthors = Goldman M, Beaumont T | title = A real world evaluation of a treatment for infant colic based on the experience and perceptions of 4004 parents | journal = British Journal of Nursing | volume = 26 | issue = 5 Suppl 1 | pages = S3–S10 | date = March 2017 | pmid = 28350192 | doi = 10.12968/bjon.2017.26.Sup5.S3 | s2cid = 32885530 }}</ref> | ||
Simethicone can also be used for suspected [[postoperative]] [[abdominal discomfort]] in infants.<ref>{{cite journal | vauthors = Voepel-Lewis TD, Malviya S, Burke C, D'Agostino R, Hadden SM, Siewert M, Tait AR | title = Evaluation of simethicone for the treatment of postoperative abdominal discomfort in infants | journal = Journal of Clinical Anesthesia | volume = 10 | issue = 2 | pages = 91–94 | date = March 1998 | pmid = 9524891 | doi = 10.1016/S0952-8180(97)00249-3 }}</ref> | |||
==Side effects== | ==Side effects== | ||
Simethicone does not have any serious side effects.<ref name="Ingold_2021" /> Two uncommon side effects (occurring in 1 in 100 to 1 in 1,000 patients) are constipation and nausea.<ref>{{cite web |title= Simethicone Side Effects in Detail |url=https://www.drugs.com/sfx/simethicone-side-effects.html| work = Drugs.com |access-date=27 August 2017}}</ref> | |||
Though poorly documented,<ref>{{cite journal | vauthors = Skelin M, Lucijanić T, Amidžić Klarić D, Rešić A, Bakula M, Liberati-Čizmek AM, Gharib H, Rahelić D | display-authors = 6 | title = Factors Affecting Gastrointestinal Absorption of Levothyroxine: A Review | journal = Clinical Therapeutics | volume = 39 | issue = 2 | pages = 378–403 | date = February 2017 | pmid = 28153426 | doi = 10.1016/j.clinthera.2017.01.005 }}</ref> some studies show a possible negative interaction between simethicone and levothyroxine, meaning it can possibly bind levothyroxine in the GI tract and hence reduce its absorption leaving the patient prone to clinical manifestations of hypothyroidism. It is important to mention the long T<sub>1/2</sub> of levothyroxine which makes the phenomenon a matter of at least a week of using levothyroxine with simethicone. To prevent this interaction, simethicone is recommended to be taken at least 4 hours before or after levothyroxine.<ref>{{cite journal | vauthors = Balapatabendi M, Harris D, Shenoy SD | title = Drug interaction of levothyroxine with infant colic drops | journal = Archives of Disease in Childhood | volume = 96 | issue = 9 | pages = 888–889 | date = September 2011 | pmid = 21785118 | doi = 10.1136/archdischild-2011-300333 }}</ref> | |||
==Pharmacology== | ==Pharmacology== | ||
Simethicone is a non-systemic [[surfactant]] which decreases the surface tension of gas bubbles in the GI tract.<ref name="Ingold_2021">{{cite book | vauthors = Ingold CJ, Akhondi H | chapter = Simethicone. | title = StatPearls [Internet]. | location = Treasure Island (FL) | publisher = StatPearls Publishing | date = January 2021 | pmid = 32310457 | chapter-url = https://www.ncbi.nlm.nih.gov/books/NBK555997/ }}</ref> This allows gas bubbles to leave the GI tract as [[flatulence]] or [[belching]].<ref name="Ingold_2021" /> Simethicone does not reduce or prevent the formation of gas.<ref>{{cite web|title=Treatment of Gas|url=https://iffgd.org/symptoms-causes/intestinal-gas/treatment.html|publisher=International Foundation for Functional Gastrointestinal Disorders|language=en-gb|date=4 September 2015}}</ref> Its effectiveness has been shown in several [[in vitro|''in vitro'']] studies.<ref>{{cite journal | vauthors = Brecević L, Bosan-Kilibarda I, Strajnar F | title = Mechanism of antifoaming action of simethicone | journal = Journal of Applied Toxicology | volume = 14 | issue = 3 | pages = 207–211 | date = May 1994 | pmid = 8083482 | doi = 10.1002/jat.2550140311 | publisher = Wiley | s2cid = 7453218 }}</ref><ref>{{cite journal | vauthors = Dittrich M, Miederer SE, Havertz B, Krastev R | title = Schaumzerstörung und Schaumverhinderung: Der Wirkmechanismus von Simeticon in vitro |journal= Journal für Gastroenterologische und Hepatologische Erkrankungen. |trans-title=Defoaming and antifoaming action of simethicone in vitro | language = German | date = 12 May 2010 | volume = 8 | issue = 3 | pages = 19–25 | url = https://www.kup.at/kup/pdf/9192.pdf | publisher=Krause & Pachernegg }}</ref> | |||
==Chemistry== | ==Chemistry== | ||
Simethicone is a mixture of [[dimethicone]] and [[silicon dioxide]].<ref name="merck-dimethicone"> {{cite encyclopedia |veditors = O'Neil MJ |encyclopedia=The Merck Index |title=Dimethicone |edition=14th |year=2006 |publisher=Merck |location=Whitehouse Station, NJ |page=545 }} </ref> | |||
==Names== | ==Names== | ||
The INN name is " | The INN name is "simethicone", which was added to the INN recommended list in 1999.<ref name=INN>{{cite journal|title=Recommended INN List 42|journal=WHO Drug Information|date=1999|volume=13|issue=3|url=https://www.who.int/medicines/publications/druginformation/innlists/RL42.pdf?ua=1|page=202}}</ref> | ||
Simethicone is marketed under many brand names and in many [[combination drugs]]; it is also marketed as a veterinary drug.<ref name=brands>{{cite web|title=Simeticone international brands|url=https://www.drugs.com/international/simeticone.html|publisher=Drugs.com|access-date=27 August 2017}}</ref> | |||
{{collapse top|Brands}} | {{collapse top|Brands}} | ||
| Line 104: | Line 103: | ||
[[Category:Digestive system]] | [[Category:Digestive system]] | ||
[[Category:Silicones]] | [[Category:Silicones]] | ||
[[Category:Over-the-counter drugs in the United States]] | |||
Latest revision as of 18:47, 22 November 2025
Template:Short description Template:Missing information Template:Short description <templatestyles src="Infobox drug/styles.css"/> Script error: No such module "Infobox".Template:Template otherScript error: No such module "TemplatePar".{{Infobox drug/maintenance categoriesTemplate:Yesno | drug_name = | INN = | _drugtype =
| _has_physiological_data= | _has_gene_therapy=
| vaccine_type= | mab_type= | _number_of_combo_chemicals=Script error: No such module "ParameterCount". | _vaccine_data= | _mab_data= | _mab_vaccine_data= | _mab_other_data=Variable | _combo_data= | _physiological_data= | _clinical_data=Template:Drugs.com COralInfacol, Wind-eze, WindSetlers, othersA03 | _legal_data=OTC
| _other_data=Poly(dimethylsiloxane), silicon dioxide
| _image_0_or_2 = Simethicone structure.svg | _image_LR =
| _datapage = Simeticone (data page) | _vaccine_target=_type_not_vaccine | _legal_all=OTC | _ATC_prefix_supplemental=A03 | _has_EMA_link = | CAS_number=8050-81-5 | PubChem=6433516 | ChemSpiderID=None | ChEBI= | ChEMBL=1200838 | DrugBank=DB09512 | KEGG= | _hasInChI_or_Key= | UNII= | _hasJmol02 = |_hasMultipleCASnumbers = |_hasMultiplePubChemCIDs = |_hasMultipleChEBIs =
| _countSecondIDs=Script error: No such module "ParameterCount". | _countIndexlabels=Script error: No such module "ParameterCount". | _trackListSortletter= |QID = |QID2 = |Verifiedfields=changed |Watchedfields= |verifiedrevid=417768970}} Simeticone (INN), also known as simethicone (USAN), is an anti-foaming agent used to reduce bloating, discomfort or pain caused by excessive gas.
Medical uses
Simethicone is used to relieve the symptoms of excessive gas in the gastrointestinal tract, namely bloating, burping, and flatulence.[1][2] While there is a lack of conclusive evidence that simethicone is effective for this use,[3][4]Script error: No such module "Unsubst". studies have shown that it can relieve symptoms of functional dyspepsia[5] and functional bloating.[6]
It has not been fully established that simethicone is useful to treat colic in babies,[7] and it is not recommended for this purpose.[4] A study in the United Kingdom reported that according to parental perception simethicone helped infant colic in some cases.[8]
Simethicone can also be used for suspected postoperative abdominal discomfort in infants.[9]
Side effects
Simethicone does not have any serious side effects.[10] Two uncommon side effects (occurring in 1 in 100 to 1 in 1,000 patients) are constipation and nausea.[11]
Though poorly documented,[12] some studies show a possible negative interaction between simethicone and levothyroxine, meaning it can possibly bind levothyroxine in the GI tract and hence reduce its absorption leaving the patient prone to clinical manifestations of hypothyroidism. It is important to mention the long T1/2 of levothyroxine which makes the phenomenon a matter of at least a week of using levothyroxine with simethicone. To prevent this interaction, simethicone is recommended to be taken at least 4 hours before or after levothyroxine.[13]
Pharmacology
Simethicone is a non-systemic surfactant which decreases the surface tension of gas bubbles in the GI tract.[10] This allows gas bubbles to leave the GI tract as flatulence or belching.[10] Simethicone does not reduce or prevent the formation of gas.[14] Its effectiveness has been shown in several in vitro studies.[15][16]
Chemistry
Simethicone is a mixture of dimethicone and silicon dioxide.[17]
Names
The INN name is "simethicone", which was added to the INN recommended list in 1999.[18]
Simethicone is marketed under many brand names and in many combination drugs; it is also marketed as a veterinary drug.[19]
Brands
|
|---|
|
Brand names include A.F., Acid Off, Aero Red, Aero-OM, Aero-Sim, Aerocol, Aerox, Aesim, Aflat, Air-X, Anaflat, Antiflat, Baby Rest, Bicarsim, Bicarsim Forte, Blow-X, Bobotic, Bobotik, Carbogasol, Colic E, Colin, Cuplaton, Degas, Dentinox, Dermatix, Digesta, Dimetikon Meda, Disflatyl, Disolgas, Elugan N, Elzym, Endo-Paractol, Enterosilicona, Espaven Antigas, Espumisan, Espumisan L, Flacol, Flapex, Flatidyl, Flatoril, Flatulex, Flucolic, Gas X, Gas-X, Gaselab, Gaseoflat, Gaseoflatex, Gaseophar, Gaseoplus, Gaseovet, Gaservol, Gasimetin, Gasnil, Gasofilm, Gastrex, Gastrosen, Gazim X, Gazix, Geludrox-HS, Genasyme, Ilio-Funkton, Imogas, Imogaze, Imonogas, Infacalm, Infacol, Infacolic, Lefax, Lefaxin, Lefoam, Logastin, Luftal, Maxi Flat, Meteosim, Metiorisan, Metsil, Mylanta, Mylicon, Mylicongas, Mylom, Mymus, Nanog, Neodrop, Neogasol, Neolanta, Orocure, Ovol, Pedicon, Phazin, Phazyme, Polysilane Junior, Restime, Rugby Gas Relief, Sab Simplex, Salinal, Semecon, Semeth, Sicongast, Siflat, Silbione, Siligas, Silipin, Sim, Simcone, Simecon, Simecrin, Simedill, Simegut, Simet, Simethicon, Simethicone, Simetic, Simeticon, Simeticona, Simeticone, Siméticone, Simeticonum, Simetigast, Simflat, Simicol, Simicon, Wilcon, Wind-eze and WindSetlers.[19] It is also marketed as a combination drug:[19]
It is also marketed as a veterinary drug under the brands Birp and Methysilox. |
References
<templatestyles src="Reflist/styles.css" />
- ↑ Script error: No such module "citation/CS1".
- ↑ Script error: No such module "citation/CS1".
- ↑ Script error: No such module "citation/CS1".
- ↑ a b Script error: No such module "citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ a b c Script error: No such module "citation/CS1".
- ↑ Script error: No such module "citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ a b c Script error: No such module "citation/CS1".
Script error: No such module "Check for unknown parameters".
Script error: No such module "Navbox".